USANA sets November 3 results date for USANA Health Sciences stock

Published on 10/15/2026 at 12:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

USANA Health Sciences stock costs EUR 13.55 on October 15, 2026. Third-quarter results are due November 3, 2026 after USD 223.00 million Q2 sales.

Reporting dates and earnings pressure

USANA will publish third-quarter results after the market closes on November 3, 2026.
Second-quarter net loss reached USD 21.4 million after a USD 29.1 million impairment charge.
USANA Health Sciences stock was trading at EUR 13.55 at 12:50 p.m. CEST at Lang & Schwarz on October 15, 2026.

USNA, US90328M1071, Illustration mit AI erstellt.

USANA Health Sciences (ISIN US90328M1071) will release its third-quarter 2026 results after the market closes on November 3, 2026. Business Wire reported the date on October 12, 2026. At Lang & Schwarz, the stock was trading at EUR 13.55 on October 15, 2026 at 12:50 p.m. CEST.

Three results dates shape the timeline

USANA's first-quarter 2026 results covered the period ended April 4, 2026, with net sales of USD 250.00 million and net earnings of USD 7.50 million, according to Business Wire. The second-quarter report covered the period ended July 4, 2026, and showed net sales of USD 223.00 million versus USD 236.00 million a year earlier.

On October 12, 2026, USANA set November 3, 2026 for the third-quarter release. The company scheduled its conference call for November 4, 2026 at 11:00 a.m. ET, according to Business Wire.

What does the second quarter mean?

The second-quarter figures show why the November release matters. USANA reported a net loss of USD 21.40 million, compared with net earnings of USD 9.70 million in the second quarter of 2025. The result included an estimated preliminary non-cash impairment charge of USD 29.10 million, while diluted earnings per share fell to negative USD 1.16 from positive USD 0.52, according to Business Wire. The impairment explains why the headline loss was larger than the underlying sales decline, but the revenue comparison still points to pressure in the operating business.

Upcoming dates and stock context

The next two scheduled events are the third-quarter results on November 3, 2026 and the earnings conference call on November 4, 2026. USANA develops nutritional supplements, functional foods and personal care products, and Business Wire says it sells directly to Brand Partners and Preferred Customers across 25 global markets.

Trading level stays in view

USANA Health Sciences stock was trading at EUR 13.55 at Lang & Schwarz on October 15, 2026 at 12:50 p.m. CEST. The November report will provide the next quantified update on sales, earnings and the effect of the impairment charge. The further course of trading is shown by the continuously updated real-time quote of USANA Health Sciences stock.